This section of the website is for UK Healthcare Professionals only. 
If you are not a Healthcare Professional, please click here.

ELATIVE Trial: Study design & baseline characteristics

Primary Biliary Cholangitis (PBC) Internal Link

The ELATIVE trial is a double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of IQIRVO in patients with PBC and inadequate response or intolerance to UDCA5

IQV-UK-000158 | January 2025

ELATIVE Trial: Study design & baseline characteristics
Explore more Primary Biliary Cholangitis (PBC) Resources

Explore more Primary Biliary Cholangitis (PBC) Resources

Browse